It is estimated that over 7 million people are living with Alzheimer's Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe's ageing population. In this series of articles, Euractiv will explore the state …
A Human-Animal Bond Report was launched at the EU Companion Animals Stakeholder Summit on 20 March in Brussels, advocating advancements in companion animal policy to improve human and animal health and wellbeing.
In early 2025, Europe will implement a uniform, pan-EU framework under the new Health Technology Assessment Regulation (HTAR), addressing disparities in evaluating the clinical value of pharmaceuticals and medical devices.
Rare Disease Day, 29 February, marks a moment when an estimated 30 million people living with rare diseases across Europe gain a louder voice. Europe now has a generational opportunity to scale up programmes capable of improving millions of lives.
The EU executive is currently conducting a comprehensive evaluation of the EU legislative framework on tobacco control, the so-called Tobacco Products Directive (TPD), including via wide public consultations. The existing Directive covers traditional cigarettes and novel products and has imposed severe restrictions.
There are millions of people in Europe who are affected by diabetes and related conditions. This number is only expected to grow in the coming years. However, with technological advancements, it is possible that those affected by the disease are able …
Download PDF
In the dynamic landscape of the EU's health-tech market, start-ups face a myriad of challenges as they strive to innovate and carve out a niche in an industry characterised by rapid technological advancements and complex regulatory landscapes. In these articles, Euractiv …
In cancer care, increasing survivorship comes with its own set of challenges, which include addressing the lasting physical and psycho-social impacts of the disease. In these articles, Euractiv looks at what is needed so that cancer survivors live their lives as …
Medical technology innovation and policy advancements are improving the transplantation experience for thousands of people in the European Union.
As the focus across the EU is usually on the prevention of stroke, post-stroke survivors are often left behind, without no national plans that take into account the need for a continuation of treatment after their discharge from medical institutions.
Gene therapies can transform the approach to rare diseases and improve the quality of life for patients. But developing and accessing them is hampered by regulatory burdens, cost and reimbursment schemes. In this special report, Euractiv takes a look at gene …
The recent years have been generous for EU health policy. COVID-19 pushed forward the creation of the European Health Union and boosted the creation of health policy files. In times of ongoing challenges that healthcare systems across the EU have …
During the European Health Forum, representatives of the pharmaceutical industry, EU institutions and patient associations discussed the next steps in fighting the ever-growing threat of antimicrobial resistance (AMR). From accessibility and incentives for research to awareness among the general public, …
The European Commission's proposed pharmaceutical strategy leaves it to the countries to decide whether the medicine information leaflet is in paper format electronic, or both. However, moving exclusively towards the electronic version could risk leaving behind those lacking digital skills.
Medical societies, patient associations, and independent experts are pressing for expedited access to innovative cancer treatments in Spain, citing a noticeable lag and lack of alternatives in the process. Spain faces a "structural problem" when assessing and funding innovative cancer drugs. …
Climate change is exacerbating threats to human health, especially affecting the health and well-being of those suffering from respiratory diseases. Air pollution is one of the biggest environmental threats to human health, causing at least 238,000 premature deaths per year, according …
How to prevent anaphylaxis and inequalities caused by divergent access to first-line emergency treatments across Europe?
Three years since the start of the COVID-19 pandemic, the African continent is still struggling to reach the 70% vaccination rate recommended by the World Health Organisation (WHO). The late arrival of vaccine doses, lack of information and the reluctance of …
The European Commission presented the eagerly-awaited pharmaceutical package on Wednesday (26 April) designed to ensure that all EU patients have timely and equitable access to safe and effective medicines while at the same time boosting the attractiveness of the EU …
The new people-centred approach embedded in the European Commission's flagship Beating cancer plan is catching on also in addressing multiple myeloma patients’ needs.
Looking for better conditions, doctors and nurses from eastern and southern Europe are moving to the West, leaving many member states with significant staff shortages.
With a freshly revamped EU regulatory framework and some of the most exciting technologies, the medical devices and diagnostics sector is on the verge of unlocking the potential of a more patient-oriented approach to health.
While the European market for food with beneficial live bacteria known as probiotics is particularly 'alive', the EU regulatory framework on the topic is stuck in 2006 blocking the potential of the sector. Requests to the European Commission for overcoming the …
Several factors have contributed to skyrocketing inflation to an all-time high of the last decades in the EU. This has resulted in significantly increased prices in every domain of the economic activity, from shipping to raw materials and energy.
